Current status of sentinel lymph node mapping in the management of endometrial cancer

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11130%2F13%3A10191850" target="_blank" >RIV/00216208:11130/13:10191850 - isvavai.cz</a>

Alternative codes found

RIV/00064203:_____/13:10191850

Result on the web

<a href="http://dx.doi.org/10.1586/ERA.12.157" target="_blank" >http://dx.doi.org/10.1586/ERA.12.157</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1586/ERA.12.157" target="_blank" >10.1586/ERA.12.157</a>

Result language

angličtina

Original language name

Current status of sentinel lymph node mapping in the management of endometrial cancer

Original language description

The prognosis of endometrial cancer (EC) is generally favorable, while lymph node status remains the most important prognostic factor. Sentinel lymph node mapping (SLNM) could help to find women in whom adjuvant therapy could be omitted. This review analyzes different techniques of injection and histopathologic elaboration of SLNM in EC. Results of studies on SLNM in ECs seem to be promising, but only a small series have been published so far. The studies are subdivided into three groups by the technique of injection (hysteroscopic, subserosal and cervical). Range of detection rate for SLNM varies from 45 to 100%. Hysteroscopic injection is not easy to learn; moreover, exact peritumoral injection in large tumors is often impossible. Subserosal administration of tracer is difficult during laparoscopic or robotic surgery. Cervical injection is quite a controversial technique because distribution of SLNs in ECs is different from cervical cancer; moreover, there is no large study using cer

Czech name

—

Czech description

—

Type

J_x - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

CEP classification

FK - Gynaecology and obstetrics

OECD FORD branch

—

Project

<a href="/en/project/NT11417" target="_blank" >NT11417: Optimization of detection and sentinel lymph nodes ultramicrostaging in endomerial carcinoma.</a><br>

Continuities

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year

2013

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Expert Review of Anticancer Therapy

ISSN

1473-7140

e-ISSN

—

Volume of the periodical

13

Issue of the periodical within the volume

1

Country of publishing house

GB - UNITED KINGDOM

Number of pages

7

Pages from-to

55-61

UT code for WoS article

000314927700013

EID of the result in the Scopus database

—